What is the significance of a 3mm nodule located in the fat anterior to the psoas muscle, below the lower pole of the left kidney, initially thought to be new on 3-year imaging follow-up after partial nephrectomy (kidney surgery), but later determined to be present 1 month post-operatively?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The 3mm nodule found in the fat anterior to the psoas muscle below the lower pole of the left kidney is most likely a benign postoperative change or scar tissue that developed after the partial nephrectomy, and no specific treatment is needed for this finding. This conclusion is supported by the fact that while it initially appeared to be new on 3-year follow-up imaging, review of earlier scans showed it was actually present 1 month after surgery 1. Such small nodules in the surgical field are common findings after kidney surgery and typically represent fibrosis, granulation tissue, or small hematomas that have organized over time.

Key Considerations

  • The location of the nodule in the perinephric fat outside the kidney parenchyma further supports its benign nature as a post-surgical change rather than a concerning lesion.
  • The American Urological Association (AUA) guidelines for follow-up after clinically localized renal neoplasms suggest that patients should undergo cross-sectional scanning (CT or MRI) with and without IV contrast at three and six months following ablative therapy to assess treatment success, but this does not directly apply to the scenario of a postoperative nodule after partial nephrectomy 1.
  • The guidelines also recommend against further radiological scanning in patients who have radiographic confirmation of treatment success and no evidence of treatment-related complications requiring further imaging, which aligns with the decision not to pursue additional imaging for this benign-appearing nodule 1.

Surveillance Approach

  • Continued routine surveillance imaging according to standard post-nephrectomy protocols is appropriate, but this specific finding does not warrant additional intervention or more frequent imaging.
  • The focus should remain on monitoring for any signs of recurrence or new pathology, following the principles outlined for post-treatment surveillance in patients after renal surgery, with adjustments based on individual patient risk factors and the specifics of their surgical and medical history 1.

From the Research

Nodule Significance

The significance of a 3mm nodule located in the fat anterior to the psoas muscle, below the lower pole of the left kidney, is uncertain based on the provided studies.

  • The nodule's location and size do not directly match the characteristics of the nodules discussed in the studies, which primarily focus on pulmonary nodules or renal masses.
  • However, some general insights can be gathered from the studies:
    • Small nodules are more likely to be benign, as seen in the study on pulmonary nodules 2 and the study on echogenic renal masses 3.
    • The study on pulmonary nodules 2 suggests that nodules smaller than 6 mm have a low probability of malignancy, and those 6 mm to 8 mm can be followed with repeat chest CT in 6 to 12 months.
    • The study on echogenic renal masses 3 found that small echogenic renal masses up to 1 cm in size are rarely malignant and can be safely ignored.

Relevance to the Nodule in Question

  • The nodule in question is located in the fat anterior to the psoas muscle, which is not directly related to the pulmonary or renal nodules discussed in the studies.
  • However, the general principle that small nodules are more likely to be benign may still apply.
  • The fact that the nodule was initially thought to be new on 3-year imaging follow-up but was later determined to be present 1 month post-operatively suggests that it may be a benign lesion that has been stable over time.

Management Options

  • Based on the studies, it is unclear what the optimal management approach would be for this specific nodule.
  • However, given its small size and stable nature, a conservative approach with serial imaging follow-up may be reasonable, similar to the approach suggested for small pulmonary nodules 2 or echogenic renal masses 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Sonographically Identified Echogenic Renal Masses Up to 1 cm in Size Are So Rarely Malignant They Can Be Safely Ignored.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 2016

Related Questions

What is the management approach for a 6mm solitary incidental lung nodule (SILN)?
What is the significance of a 13mm pulmonary nodule (pulmonary nodule)
What are the recommendations and prognosis for a 60-year-old male with a 13mm pulmonary nodule (pulmonary nodule is a small growth on the lung), also known as a lung nodule?
What is the likely diagnosis of a 2.5cm flesh-colored nodule that is painless, non-pruritic, and non-bleeding on the skin?
What is the next step in managing a 12 mm pulmonary nodule?
What is the most likely diagnosis for an 86-year-old woman with a 3 cm multicystic lesion in the head of the pancreas, confirmed by endoscopic ultrasound, with aspirated fluid analysis showing low amylase and CEA (Carcinoembryonic Antigen) levels, after being treated for diverticulitis with oral antibiotics (e.g. Hydrochlorothiazide for hypertension)?
What is the management approach for a patient with bilateral necrotic fourth toes, history of multiple stent placements, cool extremities, weak pulses, and severe left ventricular dysfunction (Ejection Fraction of 15%) with heart failure, currently on dobutamine (Dobutamine) drip in the Intensive Care Unit (ICU)?
What are the causes of elevated Lactate Dehydrogenase (LDH)?
What is the significance of a 3mm nodule in the fat anterior to the psoas muscle, below the lower pole of the left kidney, initially thought to be new on 3-year imaging follow-up after partial nephrectomy for T1a chromophobe renal cell carcinoma (RCC), but later determined to be present 1 month post-operatively?
What is the laboratory diagnosis of Epstein-Barr Virus (EBV) infection?
Is the fat anterior to the psoas (major muscle in the lower back) below the lower pole of the left kidney part of the kidney's lymphatic chain?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.